Regional variations in percutaneous absorption of methimazole: an in vitro study on cat skin.
The use of transdermal gel medications in cats has become popular in veterinary medicine due to the ease of administration compared to oral medication. The research to support systemic absorption of drugs after transdermal gel administration and the preferred skin region to apply these drugs in cats is limited. The aim of this study was to characterize the effect of different skin regions on the percutaneous absorption pharmacokinetics of a commercially available transdermal methimazole after a finite dose was applied to feline skin in vitro. A commercial formulation of methimazole (10 mg) was applied to four skin regions (the inner stratum corneum of the ear, groin, neck, and thorax regions) from six cats. The receptor medium was sampled up to 36 h postapplication, and methimazole concentrations were measured using high-performance liquid chromatography. Methimazole was absorbed more completely across the pinnal skin, compared to the groin, neck, and thorax (P < 0.001), which justifies application to the pinna to maximize efficacy and also to minimize the effects of grooming.
Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North, New Zealand.
K E
KE
Hill
Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North, New Zealand.
J P
JP
Chambers
Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North, New Zealand.
B R
BR
Jones
Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North, New Zealand.
C F
CF
Bolwell
Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North, New Zealand.
D
D
Aberdein
School of Veterinary Science, The University of Queensland, Gatton, Qld, Australia.
P C
PC
Mills
D000279:Administration, Cutaneous; D000818:Animals; D013956:Antithyroid Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002415:Cats; D005260:Female; D005782:Gels; D066298:In Vitro Techniques; D008297:Male; D008713:Methimazole / Q000008:administration & dosage / Q000493:pharmacokinetics*; D012867:Skin / Q000378:metabolism*
D013956:Antithyroid Agents; D005782:Gels; D008713:Methimazole